Clicky

Teva Pharmaceutical Industries Ltd(TEVA) News

Date Title
Oct 31 Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
Oct 31 EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Oct 31 Teva Statement on European Commission Decision; Company to Appeal
Oct 11 Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
Oct 11 Update: Teva Pharmaceutical to Pay $450 Million to Settle Anti-Kickback Allegations
Oct 10 Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations
Oct 9 Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
Oct 8 Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Jul 29 Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
Jul 29 Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
Jul 25 Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
Jun 24 Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
Jun 24 Here's Why You Should Consider Buying Alvotech (ALVO) Stock
Jun 22 Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?
May 21 Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
May 17 Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
Apr 6 New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
Apr 4 Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Apr 3 3 No-Brainer Stocks to Buy With $600 Right Now
Apr 3 Biden and Senator Sanders to highlight efforts lower cost of asthma inhalers